peaceiris / actions-hugo

GitHub Actions for Hugo ⚡️ Setup Hugo quickly and build your site fast. Hugo extended, Hugo Modules, Linux (Ubuntu), macOS, and Windows are supported.
https://github.com/marketplace/actions/hugo-setup
MIT License
1.38k stars 80 forks source link

ci: bump actions/dependency-review-action from 1 to 2 #593

Closed dependabot[bot] closed 1 year ago

dependabot[bot] commented 2 years ago

Bumps actions/dependency-review-action from 1 to 2.

Release notes

Sourced from actions/dependency-review-action's releases.

2.0.0

Major version update! We are introducing a few configuration options to make the action more useful in a broader set of scenarios:

  • fail-on-severity: Specify the minimum security vulnerability threshold before failing workflow runs.
  • allow-licenses: An allowlist for dependency licenses.
  • deny-licenses: A blocklist for dependency licenses.

You can read more about these options in the README.

PS: No breaking changes since v1.

1.0.2

  • Clarify error messages for private repos
  • Update NPM dependencies.

v1.0.1

We're starting to use semantic versioning for our project.

Commits


Dependabot compatibility score

Dependabot will resolve any conflicts with this PR as long as you don't alter it yourself. You can also trigger a rebase manually by commenting @dependabot rebase.


Dependabot commands and options
You can trigger Dependabot actions by commenting on this PR: - `@dependabot rebase` will rebase this PR - `@dependabot recreate` will recreate this PR, overwriting any edits that have been made to it - `@dependabot merge` will merge this PR after your CI passes on it - `@dependabot squash and merge` will squash and merge this PR after your CI passes on it - `@dependabot cancel merge` will cancel a previously requested merge and block automerging - `@dependabot reopen` will reopen this PR if it is closed - `@dependabot close` will close this PR and stop Dependabot recreating it. You can achieve the same result by closing it manually - `@dependabot ignore this major version` will close this PR and stop Dependabot creating any more for this major version (unless you reopen the PR or upgrade to it yourself) - `@dependabot ignore this minor version` will close this PR and stop Dependabot creating any more for this minor version (unless you reopen the PR or upgrade to it yourself) - `@dependabot ignore this dependency` will close this PR and stop Dependabot creating any more for this dependency (unless you reopen the PR or upgrade to it yourself)
codecov[bot] commented 2 years ago

Codecov Report

Base: 97.85% // Head: 100.00% // Increases project coverage by +2.14% :tada:

Coverage data is based on head (9ea3e00) compared to base (bd5a5ed). Patch has no changes to coverable lines.

Additional details and impacted files ```diff @@ Coverage Diff @@ ## main #593 +/- ## =========================================== + Coverage 97.85% 100.00% +2.14% =========================================== Files 7 7 Lines 140 140 Branches 20 20 =========================================== + Hits 137 140 +3 + Misses 3 0 -3 ``` | [Impacted Files](https://codecov.io/gh/peaceiris/actions-hugo/pull/593?src=pr&el=tree&utm_medium=referral&utm_source=github&utm_content=comment&utm_campaign=pr+comments&utm_term=Shohei+Ueda) | Coverage Δ | | |---|---|---| | [src/installer.ts](https://codecov.io/gh/peaceiris/actions-hugo/pull/593/diff?src=pr&el=tree&utm_medium=referral&utm_source=github&utm_content=comment&utm_campaign=pr+comments&utm_term=Shohei+Ueda#diff-c3JjL2luc3RhbGxlci50cw==) | `100.00% <0.00%> (+5.88%)` | :arrow_up: | Help us with your feedback. Take ten seconds to tell us [how you rate us](https://about.codecov.io/nps?utm_medium=referral&utm_source=github&utm_content=comment&utm_campaign=pr+comments&utm_term=Shohei+Ueda). Have a feature suggestion? [Share it here.](https://app.codecov.io/gh/feedback/?utm_medium=referral&utm_source=github&utm_content=comment&utm_campaign=pr+comments&utm_term=Shohei+Ueda)

:umbrella: View full report at Codecov.
:loudspeaker: Do you have feedback about the report comment? Let us know in this issue.